Product Details
Place of Origin: China
Brand Name: BBCA Pharma
Model Number: 26787-78-0
Payment & Shipping Terms
Safetyinformation: |
Keep Out Of Reach Of Children |
Countryoforigin: |
Specified By Supplier |
Form: |
Powder |
Type: |
OTC |
Manufacturer: |
Specified By Supplier |
Active Ingredient: |
Paracetamol |
Productname: |
Powder For Oral |
Activeingredients: |
Varies By Formulation |
Safetyinformation: |
Keep Out Of Reach Of Children |
Countryoforigin: |
Specified By Supplier |
Form: |
Powder |
Type: |
OTC |
Manufacturer: |
Specified By Supplier |
Active Ingredient: |
Paracetamol |
Productname: |
Powder For Oral |
Activeingredients: |
Varies By Formulation |
The Powder For Oral product is a highly effective pharmaceutical formulation designed for oral administration. This product is primarily available in powder form, which must be reconstituted by mixing with water before consumption. Once properly prepared, it transforms into a suspension that facilitates easy and accurate dosing, making it an ideal choice for patients who have difficulty swallowing tablets or capsules. The powder form ensures a longer shelf life and stability, maintaining its efficacy over an extended period.
One of the key highlights of this product is its association with well-known antibiotics such as Amoxicillin and Amoxicillin and Clavulanate Potassium for Suspension. These antibiotics are widely used to treat a variety of bacterial infections, and the powder formulation for oral suspension allows for flexible dosing, especially in pediatric and geriatric patients. Amoxicillin and Clavulanate Potassium for Suspension is particularly valued for its broad-spectrum antibacterial activity, combining the efficacy of Amoxicillin with the protective benefits of Clavulanate Potassium, which helps overcome bacterial resistance.
The product's country of origin is specified by the supplier, ensuring transparency and traceability. This allows healthcare providers and consumers to have confidence in the manufacturing standards and quality control processes adhered to during production. The powder's packaging is designed to preserve its integrity and potency throughout its shelf life, which extends up to 3 years when stored under recommended conditions. This long shelf life makes the product convenient for both healthcare facilities and patients, reducing the need for frequent repurchasing and minimizing wastage.
Instructions for use are straightforward and user-friendly. Before administration, the powder must be mixed with a specified amount of water to create a suspension. This process ensures that the medication is evenly distributed throughout the liquid, allowing for consistent dosing with each administration. The oral route of administration enhances patient compliance, as it avoids the discomfort associated with injections and allows for easy integration into daily routines. The suspension form is especially beneficial for children or individuals who may have difficulty swallowing solid dosage forms.
In clinical practice, Amoxicillin and Clavulanate Potassium for Suspension prepared from this powder is commonly prescribed for infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections sensitive to these antibiotics. The combination of Amoxicillin with Clavulanate Potassium extends the spectrum of antibacterial activity, making the suspension an effective treatment option for resistant bacterial strains. This product plays a critical role in antimicrobial therapy, supporting health outcomes and contributing to the management of infectious diseases.
Overall, the Powder For Oral product is a versatile, reliable, and efficient pharmaceutical preparation. Its powder form offers stability and longevity, while its ability to be converted into a suspension makes it practical for a wide range of patients. With a shelf life of 3 years and clear instructions for use, it provides a dependable solution for administering Amoxicillin and Amoxicillin and Clavulanate Potassium for Suspension. The oral route of administration further enhances its accessibility and ease of use, making it a preferred choice in both hospital and home care settings. By choosing this product, healthcare professionals can ensure effective delivery of antibiotic therapy, promoting better patient outcomes and supporting public health initiatives against bacterial infections.
| Active Ingredient | Paracetamol |
| Shelf Life | 3 Years |
| Product Name | Powder For Oral |
| Grade | Medicine Grade |
| Form | Powder |
| Instructions for Use | Mix With Water Before Consumption |
| Country of Origin | Specified By Supplier |
| Type | OTC |
| Route of Administration | Oral |
| Dosage Form | Dry Suspension |
The Powder For Oral product by BBCA Pharma, model number 26787-78-0, is a highly effective dry suspension designed for versatile use in various medical scenarios. Originating from China and manufactured by a supplier specified by BBCA Pharma, this product offers a reliable and convenient dosage form that ensures ease of administration and optimal patient compliance. With a shelflife of 3 years, this powder suspension remains stable and effective over time, making it an essential addition to both clinical and home healthcare settings.
The primary active ingredients in this formulation vary by specific formulations, allowing healthcare providers to tailor the treatment according to patient needs. Notably, the product includes Amoxicillin and Clavulanate Potassium for Suspension, a well-known combination that effectively combats bacterial infections by enhancing the efficacy of amoxicillin through clavulanate potassium's beta-lactamase inhibition. This makes the suspension ideal for treating a wide range of infections, including respiratory tract infections, urinary tract infections, skin infections, and more.
The Powder For Oral product is especially useful in pediatric and adult care where liquid suspensions are preferred over tablets or capsules due to swallowing difficulties or dosage flexibility. It can be easily reconstituted into suspension form, ensuring accurate dosing and ease of administration. This makes it highly suitable for outpatient treatment, hospital use, and emergency medical situations where quick and effective antibiotic therapy is required.
Safety is a crucial aspect of this product’s design. The packaging clearly advises users to keep the suspension out of reach of children, emphasizing the importance of proper storage and handling. This precaution helps prevent accidental ingestion and ensures safe use within households and clinical environments alike.
In summary, BBCA Pharma’s Powder For Oral product, featuring Amoxicillin and Clavulanate Potassium for Suspension, is an indispensable pharmaceutical suspension. It is suited for diverse application occasions such as pediatric care, outpatient therapy, hospital treatments, and emergency situations where effective antibacterial action is critical. Its dry suspension form, long shelflife, and adaptable active ingredients make it a versatile and trusted choice for healthcare professionals and patients worldwide.
BBCA Pharma offers customized Powder For Oral products designed to meet your specific requirements. Our product, model number 26787-78-0, originates from China and is manufactured by a supplier specified to ensure high quality. The powder form is ideal for oral consumption and can be formulated to include key active ingredients such as Amoxicillin and Clavulanate Potassium. We also provide options for suspension preparations to suit various medical needs. Trust BBCA Pharma for reliable and tailored pharmaceutical solutions.